University of Vienna
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 1365-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.univie.ac.at
Clinical Trials
44
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (33 trials with phase data)• Click on a phase to view related trials
Youth Mental Health Recovery in the Family After Inpatient Stay
- Conditions
- Caregiver BurdenFamily CharacteristicsParent-Child Interactions
- First Posted Date
- 2025-03-10
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- University of Vienna
- Target Recruit Count
- 70
- Registration Number
- NCT06865573
Hop Compounds on the Immune System in Overweight People
- Conditions
- Inflammatory Response
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- University of Vienna
- Target Recruit Count
- 24
- Registration Number
- NCT06745102
- Locations
- 🇦🇹
University of Vienna, Vienna, Austria
Influence of Specific Collagen Peptides on Training-Induced Metabolic and Biomechanical Adaptations of Skeletal Muscle
- Conditions
- Collagen Supplementation
- First Posted Date
- 2024-11-14
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- University of Vienna
- Target Recruit Count
- 60
- Registration Number
- NCT06689761
- Locations
- 🇦🇹
Centre for Sport Science and University Sports, Department of Sport and Human Movement Science, Vienna, Austria
Balance, Autonomic Response, and Sensory Modulation to Dosage of Mechanical Vagal Stimulation in Healthy Adults
- Conditions
- Vagus Nerve Autonomic DisorderHeart RatePainEquilibrium; Disorder, LabyrinthMicrobial Colonization
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- University of Vienna
- Target Recruit Count
- 128
- Registration Number
- NCT06541808
- Locations
- 🇦🇹
UVienna, Vienna, Wien, Austria
Nitrate, Exercise and Vascular Function in Midlife Women
- Conditions
- MenopauseHealthyInflammationHypertension
- First Posted Date
- 2024-07-30
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- University of Vienna
- Target Recruit Count
- 54
- Registration Number
- NCT06527248
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
News
Federal Appeals Court Reopens CRISPR Patent Battle, Giving Nobel Laureates New Hope
A U.S. appeals court has vacated a 2022 patent ruling, reopening the dispute over who first invented CRISPR gene editing in human cells between Nobel laureates Doudna/Charpentier and the Broad Institute's Feng Zhang.
Federal Circuit Remands CRISPR Patent Dispute to PTAB in Ongoing Editas Medicine Case
The U.S. Court of Appeals for the Federal Circuit has partially vacated the Patent Trial and Appeal Board's previous decision in the CRISPR/Cas9 patent interference case, remanding it for further review.